Tandem Diabetes Care, Inc. (TNDM)
NASDAQ • Healthcare
Last close at September 9, 2026 at 20:00 UTC
Metrics Over Time
Where the Money Goes
Q2 2026In plain terms: out of every $100 in revenue, Tandem Diabetes Care, Inc. currently loses $8.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Nov 5
in 56 daysQ4 2026% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
About Tandem Diabetes Care, Inc.
Tandem Diabetes Care, Inc. develops insulin-delivery technology and related diabetes-management software in the medical device business. Listed on the NASDAQ as TNDM, the company sells its products globally and generated $1.0 billion of revenue in FY2025, with that business spanning connected pump hardware and software for diabetes care.
Today's Snapshot
Yesterday TNDM fell 3.9% to 19.11.
Trading Volume
Above 10d avg 1.3M
1.5M
vs S&P 500 Today
Strong Underperformance
-3.39%
Updated: September 10, 2026 at 12:03 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$18.92 - $20.84Sell
- RSI (14)37.76Neutral
- Stochastic %K (14, 3, 3)6.42Buy
- MACD Level (12, 26)-0.01Sell
Peers & Related Assets
Get premium market insights delivered directly to your inbox.